Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib. [PDF]
Natoli V+11 more
europepmc +1 more source
Juvenile Dermatomyositis: Updates in Pathogenesis and Biomarkers, Current Treatment, and Emerging Targeted Therapies. [PDF]
Kim H.
europepmc +1 more source
Increased vascular deposition of oxidized LDL in untreated juvenile dermatomyositis. [PDF]
Spitznagle JC+4 more
europepmc +1 more source
Interferon-β-Induced Injury During Pediatric Muscle Differentiation: Insight Into Juvenile Dermatomyositis Pathogenesis. [PDF]
Covert LT, Osman A, Truskey GA.
europepmc +1 more source
Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity Index. [PDF]
Rosina S+14 more
europepmc +1 more source
Neutrophil and mononuclear leukocyte pathways and upstream regulators revealed by serum proteomics of adult and juvenile dermatomyositis. [PDF]
Sparling AC+11 more
europepmc +1 more source
The value of quantitative muscle ultrasound in monitoring muscle and fascia inflammatory activity in juvenile dermatomyositis patients. [PDF]
Liu L+5 more
europepmc +1 more source
Penicillamine-Induced Juvenile Dermatomyositis: A Rare Clinical Encounter. [PDF]
Solanki VG+3 more
europepmc +1 more source
TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients. [PDF]
Nguyen HD+16 more
europepmc +1 more source